The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling.
Level 5 - mechanism / opinion, no new human data
In vitro mechanistic laboratory study without human subjects.
PubMed 27304884 · doi:10.1371/journal.pone.0157430
What was done
The authors investigated the molecular mechanism of moringin (GMG-ITC), an isothiocyanate derived from Moringa oleifera seeds, compared to sulforaphane (SFN). Using in vitro cell systems, they tested the effects of GMG-ITC on IL-3-induced STAT5 target gene expression and phosphorylation, IFN-alpha-induced STAT1 and STAT2 activation, TNF-induced NF-kappaB activity, and cell survival in a model of constitutively active STAT5-mediated cell transformation.
What was found
Nanomolar concentrations of GMG-ITC suppressed IL-3-induced expression of STAT5 target genes without blocking STAT5 phosphorylation, matching the behavior of SFN. Both GMG-ITC and SFN showed limited inhibitory activity against IFN-alpha-induced STAT1 and STAT2 signaling. At micromolar concentrations, GMG-ITC inhibited TNF-induced NF-kappaB activity more potently than SFN. SFN triggered cell death and reversed growth advantages in cells transformed by constitutively active STAT5. Exact numerical values, IC50 values, and effect sizes were not reported in the abstract.
Why it matters
This study identifies STAT5 and NF-kappaB signaling pathways as molecular targets of the dietary phytochemical moringin, providing a mechanistic basis for its potential chemopreventive properties.
Limits
The experiment was conducted entirely in cell culture models with no in vivo animal models or human participants. The abstract does not report exact concentrations, quantitative effect sizes, or confidence intervals. In vivo bioavailability, pharmacokinetics, and clinical relevance cannot be determined from these in vitro assays.
Cited by
- supports Moringin, the primary isothiocyanate found in Moringa, exhibits greater bioactivity or potency than sulforaphane in several laboratory assays.